2.1
Abaloparatide (Eladynos, Theramex) is indicated for the 'treatment of osteoporosis in postmenopausal women at increased risk of fracture'.
2 Information about abaloparatide
Marketing authorisation indication
Dosage in the marketing authorisation
2.2
The dosage schedule is available in the summary of product characteristics for abaloparatide.
Price
2.3
The list price of abaloparatide is £294.54 per pre-filled pen (excluding VAT, company submission). Each pre-filled pen contains 3 mg abaloparatide in 1.5 ml of solution (30 doses).
2.4
The company has a commercial arrangement. This makes abaloparatide available to the NHS with a discount. The size of the discount is commercial in confidence.